49 jili cc Kobe Sanders, Nevada beat Oklahoma St. for fifth place in CharlestonBy JOSH BOAK and ZEKE MILLER, The Associated Press WASHINGTON — Working-class voters helped Republicans make steady election gains this year and expanded a coalition that increasingly includes rank-and-file union members, a political shift spotlighting one of President-elect Donald Trump’s latest Cabinet picks: a GOP congresswoman, who has drawn labor support, to be his labor secretary. Oregon Rep. Lori Chavez-DeRemer narrowly lost her bid for a second term this month, despite strong backing from union members, a key part of the Democratic base but gravitating in the Trump era toward a Republican Party traditionally allied with business interests. “Lori’s strong support from both the Business and Labor communities will ensure that the Labor Department can unite Americans of all backgrounds behind our Agenda for unprecedented National Success – Making America Richer, Wealthier, Stronger and more Prosperous than ever before!” Trump said in a statement announcing his choice Friday night. For decades, labor unions have sided with Democrats and been greeted largely with hostility by Republicans. But with Trump’s populist appeal, his working-class base saw a decent share of union rank-and-file voting for Republicans this year, even as major unions, including the AFL-CIO and the United Auto Workers, endorsed Democrat Kamala Harris in the White House race. Trump sat down with the International Brotherhood of Teamsters union leadership and members this year, and when he emerged from that meeting, he boasted that a significant chunk of union voters were backing him. Of a possible Teamsters endorsement, he said, “Stranger things have happened.” The Teamsters ultimately declined to endorse either Trump, the former president, or Harris, the vice president, though leader Sean O’Brien had a prominent speaking slot at the Republican National Convention. Kara Deniz, a Teamsters spokesperson, told the Associated Press that O’Brien met with more than a dozen House Republicans this past week to lobby on behalf of Chavez-DeRemer. “Chavez-DeRemer would be an excellent choice for labor secretary and has his backing,” Deniz said. The work of the Labor Department affects workers’ wages, health and safety, ability to unionize, and employers’ rights to fire employers, among other responsibilities. On Election Day, Trump deepened his support among voters without a college degree after running just slightly ahead of Democrat Joe Biden with noncollege voters in 2020. Trump made modest gains, earning a clear majority of this group, while only about 4 in 10 supported Harris, according to AP VoteCast, a sweeping survey of more than 120,000 voters nationwide. Roughly 18% of voters in this year’s election were from union households, with Harris winning a majority of the group. But Trump’s performance among union members kept him competitive and helped him win key states such as Pennsylvania, Michigan and Wisconsin. Chavez-DeRemer was one of few House Republicans to endorse the “Protecting the Right to Organize” or PRO Act, which would allow more workers to conduct organizing campaigns and add penalties for companies that violate workers’ rights. The measure would weaken “right-to-work” laws that allow employees in more than half the states to avoid participating in or paying dues to unions that represent workers at their places of employment. Trump’s first term saw firmly pro-business policies from his appointees across government, including those on the National Labor Relations Board. Trump, a real estate developer and businessman before winning the presidency, generally has backed policies that would make it harder for workers to unionize. During his recent campaign, Trump criticized union bosses, and at one point suggested that UAW members should not pay their dues. His first administration did expand overtime eligibility rules, but not nearly as much as Democrats wanted, and a Trump-appointed judge has since struck down the Biden administration’s more generous overtime rules. He has stacked his incoming administration with officials who worked on the Heritage Foundation’s “Project 2025” blueprint, which includes a sharp swing away from Biden’s pro-union policies. “Chavez-DeRemer’s record suggests she understands the value of policies that strengthen workers’ rights and economic security,” said Rebecca Dixon, president and CEO of National Employment Law Project, which is backed my many of the country’s major labor unions. “But the Trump administration’s agenda is fundamentally at odds with these principles, threatening to roll back workplace protections, undermine collective bargaining, and prioritize corporate profits over the needs of working people. This is where her true commitment to workers will be tested.” Other union leaders also issued praise, but also sounded a note of caution. “Educators and working families across the nation will be watching ... as she moves through the confirmation process,” the president of the National Education Association, Becky Pringle, said in a statement, “and hope to hear a pledge from her to continue to stand up for workers and students as her record suggests, not blind loyalty to the Project 2025 agenda.” AFL-CIO President Liz Shuler welcomed the choice while taking care to note Trump’s history of opposing polices that support unions. “It remains to be seen what she will be permitted to do as secretary of labor in an administration with a dramatically anti-worker agenda,” Shuler said.Georgescu’s victory would lead to power shifting to the adherents of Romania’s sovereignty who are regarded by the powers that be as radicals and anti-system elements, he explains. “Therefore, these pillars of Romania’s current political elite – social democrats and national liberals first and foremost, and President Iohannis represents national liberals – they could make such decision and force the Constitutional Court to approve it,” Ciurea remarks. Georgescu never declared himself as a pro-Russian politician, Ciurea noted, he merely wants peace in the region, which in turn would mean resolving the Ukrainian conflict – something that Romania’s political elite does not want. These views of his led to Georgescu being automatically branded as pro-Russian, which is unacceptable in Romania and by default pushes them to the political fringe, Ciurea explains. This, he says, allows the Romanian political elite to regard Georgescu as an extremist. Yesterday, 10:40 GMT Tatiana Bitkova, senior researcher at the Russian Academy of Sciences (INION RAN), offers a similar take on the subject, adding that foreign powers – namely, the “Euro-Atlantic institutions” – were interested in seeing Georgescu fail. She points out that the Romanian Constitutional Court the entire election process was definitely abnormal. Ciurea, too, concurs that Georgescu’s victory in Romania, a country where the US normally maintains “complete political control,” would have been an inconvenience to the United States. Therefore, he believes that the fact that Georgescu was a step away from winning the election drove the current US elites to “take certain measures.” “I think that this decision to annul the election results is, in principle, a ban on Georgescu’s victory,” Ciurea says. He compares this development to the situation in Georgia where the US and the EU are trying to influence the recent election results, adding that tensions there are rising.

Vivos Therapeutics, Inc. ( NASDAQ:VVOS – Get Free Report ) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 148,000 shares, a growth of 28.9% from the November 30th total of 114,800 shares. Approximately 3.9% of the company’s stock are short sold. Based on an average daily volume of 207,100 shares, the days-to-cover ratio is currently 0.7 days. Analysts Set New Price Targets Several brokerages have issued reports on VVOS. Ascendiant Capital Markets reaffirmed a “buy” rating and issued a $6.60 target price on shares of Vivos Therapeutics in a report on Wednesday, November 20th. Alliance Global Partners decreased their price objective on shares of Vivos Therapeutics from $8.25 to $6.00 and set a “buy” rating for the company in a report on Tuesday, November 19th. View Our Latest Stock Report on VVOS Vivos Therapeutics Price Performance Vivos Therapeutics Company Profile ( Get Free Report ) Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Further Reading Receive News & Ratings for Vivos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .PINE BLUFF, Ark. (AP) — Quintell Quinn ran for 154 yards and two touchdowns to lead Texas Southern to a 31-23 victory over Arkansas-Pine Bluff on Saturday. Quinn scored on a 32-yard run to open the scoring midway through the first quarter, and his 75-yard touchdown run gave Texas Southern a 17-13 lead with 6:59 remaining in the third. A little more than three minutes later, Jace Wilson threw a 21-yard touchdown pass to Trenton Leary that stretched the Tigers' lead to 24-13. Athean Renfro added 55 yards rushing with a 1-yard TD run in the fourth quarter for Texas Southern (5-6, 4-4 Southwestern Athletic Conference). DJ Stevenson threw a touchdown pass and an interception for Arkansas-Pine Bluff (3-8, 2-6). Abdulbasit Osholake had an 80-yard pick-6 that tied it 7-all late in the second quarter for the Lions. ___ Get alerts on the latest AP Top 25 poll throughout the season. Sign up here ___ AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.Warning not to share ADHD medicine, as shortage bites

3 No-Brainer Fintech Stocks to Buy Right Now for Less Than $1,000CENTURION (AFP): An emotional Temba Bavuma hailed the character of his team after South Africa qualified for the World Test championship final with a dramatic two-wicket win over Pakistan on the fourth day of the first Test at SuperSport Park on Sunday. Needing 148 to win, South Africa crashed to 99 for eight owing to superb bowling by Mohammad Abbas. But Kagiso Rabada turned batting hero as he and Marco Jansen took South Africa to victory with an unbeaten ninth wicket partnership of 51. Rabada, so often a match-winner as a bowler, went on the attack as a batsman, hitting an unbeaten 31 off 26 balls, while Jansen provided solid support in making 16 not out. “It is an emotional moment for me,” South African captain Bavuma said at the post-match presentation. “As a team, we have overcome a lot. We haven’t been super-dominant with our performances, we haven’t been ruthless but we have always found a way to ensure the result was on our side. “Today was testament to that. It speaks a lot to the talent and character of the group.” South Africa’s win meant that only one of Australia and India can qualify for the final at Lord’s in June. Pakistan captain Shan Masood said he was proud of the effort of his players but lamented the failure to take ruthless advantage of their opportunities. “Twice we had them eight down and with the bat we could have extended our first innings and could have extended our lead (in the second innings). We have to learn to seize the moments.” ‘The only spike’ Masood said Abbas, playing in his first Test in more than three years, had been “sensational”. The 34-year-old Abbas took a career-best six for 54. He bowled unchanged for 19.3 overs –- four of them on Saturday when he took his first two wickets -– in a spell of unremitting accuracy on a pitch which gave seam bowlers help throughout the match. Man of the match Aiden Markram and Bavuma batted solidly at the start of the day after resuming on 27 for three. However, Markram was bowled by Abbas for 37 by a virtually unplayable ball which kept low and seamed back off the pitch. Bavuma and David Bedingham added another 34 runs until Bavuma uncharacteristically charged down the pitch at Abbas and was given out caught behind for 40. He walked off immediately but Ultra Edge technology showed the only ‘spike’ was when the ball brushed his trouser pocket. It was the first of four wickets which fell for three runs in 12 balls. Naseem Shah bowled Kyle Verreynne and Abbas had Bedingham and Corbin Bosch caught behind off successive deliveries. Rabada and Jansen saw South Africa through to lunch at 116 for eight -– then polished off the match in just 5.3 overs after the interval, with each stroke cheered by the home spectators. Both sides have a short break before they meet for the second and final Test in Cape Town on January 3.

Adele has opened up about how her two-year Las Vegas residency got off to a "rocky" start. or signup to continue reading The Chasing Pavements singer, 36, mounted the gigs after a traumatic time in 2022 which saw her cancel the shows less than a day before the first one was set to kick off – and wrapped them up on Saturday night with an emotional performance at Caesars Palace that saw her kiss her 12-year-old son Angelo and fiancée Rich Paul, 43, after making a speech to fans about her battle to put them on. She told the crowd in a video shared on social media: "I am so sad that this residency is over and I am so glad that it happened – I really, really am. "It got off to such a f****** rocky, rocky way. It was one of the worst years of my life. "I was being punched around, it was horrible and I was told it was career suicide and Vegas would never forgive me for (cancelling) so last minute." Ahead of her last show on Saturday, Adele told how she was looking forward to enjoying red wine and resting in bed. She told fans at one of her recent shows in Sin City, she said: "Doing four hours a weekend of completely live singing is a lot. "And I chat a lot, and I'm very, very sensitive and I'm emotional. I am battered after these shows. And I take every single person on in this room into my soul, I take you home with me. She added she's been on "full recovery" between shows and was ready for them to be over. Adele went on: "It's a big deal to me because it's very, very bittersweet. But (my residency) has been in my mind for four years... four years for one f****** idea. "So I'm looking forward to having loads of spare time to love on my kids, to love on my man and to love on another kid. To love on my house. "Saturday night (when the residency ends), I'm probably going to have a (lot) of red wine. "So that's the most exciting thing for when the show ends! Then after that I think I'm just going to really, really veg until the end of the year. I feel like I'm early hibernating already." Advertisement Sign up for our newsletter to stay up to date. We care about the protection of your data. Read our . AdvertisementWireless Concrete Sensor Market Analysis By Top Keyplayers - HILTI, Giatec, AKCP, Wake, Maturix, Lumicon, Converge, HGCR Technologies, Sensytec, Resensys, EXACT, PERI, Concrete Sensors, Doka, ConCure, Exact Technology, ONSET, AOMS Technologies

As the rising star of cell therapy biotechs, Iovance Biotherapeutics ( IOVA 3.76% ) is a hot stock that's capturing a lot of attention, and for good reason. Iovance's one-of-a-kind medicine is already selling like hotcakes, and there's reason to believe that plenty more growth is on the way. Let's take a look at why this stock is worth purchasing today and never looking back. Today, Iovance has a trio of bullish drivers are the legs of the stock's investment thesis. A rapidly growing market First, Iovance's first cell therapy to be approved for sale, Amtagvi, is quickly finding its home in the market. This year, management estimates that sales of the therapy will bring in at least $160 million in revenue, with 2025's sum totaling at least $450 million. So investors who buy the stock soon will be, in theory, exposed to a tripling of the top line in the near term, which is bullish. In practice, the biotech is taking the actions needed to deliver on that ambitious goal for next year. Amtagvi is intended to treat patients who have advanced melanoma and who have already been treated with a common immunotherapy drug called pembrolizumab. Per management, its total addressable market is thus roughly between 20,000 and 30,000 patients annually. Serving those patients will require expanding the company's network of authorized treatment centers (ATCs). It's targeting a total of 70 ATCs in the U.S. before the end of the year, and progress is on track. Expanding manufacturing capability Another major initiative is expanding the company's manufacturing capacity for Amtagvi. Its current plans call for the expansion of one of its current facilities so it can generate doses for around 5,000 patients annually within the next few years, but it's also building up a network of contract manufacturers such that it can eventually treat an additional 15,000 patients per year. If those efforts are successful, it'll support Iovance's margins by controlling its cost of goods sold (COGS) . It might also be feasible for it to license out its facilities to produce cell therapies for other biopharma businesses, if it demonstrates exceptional competency in cell manufacturing. So the odds that Iovance will make good on its revenue estimates are decidedly favorable, and there's a clear runway for organic growth to continue after meeting them. A possible expansion of indications Finally, with a bit more research and development (R&D) work in the form of clinical trials testing Amtagvi in different oncology contexts, and in combination with pembrolizumab instead of only after a course of treatment, management thinks that it could one day treat as many as 70,000 patients with advanced melanoma globally. That'd expand its total addressable market by more than double, and likely require more manufacturing investments. Still, this is another bullish catalyst that is hard to ignore. The most important clinical trial is a study that's in phase 3 right now, investigating whether Amtagvi can be administered alongside pembrolizumab as a first line treatment. Being a first line treatment would lead to faster adoption of the therapy, rewarding shareholders in the process. The long haul could be even better Next year, Iovance will sync with regulators in Australia and Switzerland to see if they're willing to approve Amtagvi. It should also hear back from regulators in Canada, the U.K., and the E.U. in the same period, making for three potential catalysts and more revenue down the line. While it's true that there will be some lingering long-term execution risks relating to its cell manufacturing platform, the unique nature of its therapy means that it will likely retain the ability to draw on additional capital by taking out loans or issuing more shares of its stock. It'll probably need to do that before it becomes profitable at some point in the next few years. Nonetheless, as more and more patients globally gain access to Amtagvi, this company will have a lot of room to continue growing. Given Iovance's strong start to the therapy's commercialization, it's worth buying this stock.AP News Summary at 9:47 p.m. EST

75% LOCAL CONTENT FOR PUBLIC BROADCASTERSLOS ANGELES –– The Kings defeated one of the NHL’s hottest teams and turned in a perfect afternoon on special teams as they beat the Seattle Kraken 2-1 on Saturday at Crypto.com Arena. The Kings scored the game’s only power-play goal, reversing a troubling recent trend in the process, and were 3 for 3 on the penalty kill. They entered the match as losers of three of their last four games while Seattle had prevailed in five of its past six clashes. Adrian Kempe and Quinton Byfield, who was playing in his 200th career game, each found the net for the Kings. Anže Kopitar assisted on both goals. David Rittich stopped all 19 shots. Brandon Montour scored late for Seattle on an active night for the former Ducks defenseman. Joey Daccord made 19 saves. Two of the NHL’s 10 best teams defensively produced a predictably low-event first period – while the Kraken and Kings once combined for 17 goals in a game, they had only nine combined shots in the opening 20 minutes – but the Kings flipped the script with goals at the 4:19 and 6:03 marks of the middle frame. First, it was the vision of Alex Turcotte synergizing the finishing ability of Kempe, who scored his 10th goal of the season and his 11th point in his past 11 games. Turcotte received the puck behind the net, curled toward the right-wing boards and sold a play along the wall as he sucked in four Kraken defenders. His no-look pass hit Kempe in the slot, with Adam Larsson unable to close his gap and Daccord having little chance at Kempe’s searing short-side wrister. Then, two weights were lifted at once when the power play scored its first goal since Brandt Clarke’s Nov. 9 empty-netter and Byfield tallied for the first time since he scored in consecutive games Nov. 5 and Nov. 7. He scored his third goal of the year and the first for the newly configured top power-play unit with a kneeling one-timer from the right faceoff circle. The primary assist was Kevin Fiala’s first point in seven games and the secondary one, as it did on Kempe’s goal, went to Kopitar. The captain’s pair of helpers brought him to 14 points in his past 11 games, remaining a beacon of consistency even in lean offensive stretches for the team. The Kings had the opportunity to slam the door at the end of the period when a bizarre sequence during a Seattle power play left Byfield and Warren Foegele with a two-on-none shorthanded rush. After four passes across Daccord’s crease, Foegele’s eventual shot was negated by the handle of Daccord’s stick. Foegele would have another brush with glory in the third period, right after Montour had two of his own. His slap shot was saved by Rittich but his follow-up bid beat the big Czech, only to dent the right post just below the crossbar. Montour broke through 23 seconds after the Kings survived a six-on-four sequence, when his slap shot roared past Rittich with 1:34 to play, but Seattle drew no nearer.

No. 16 Iowa State falls short in Big 12 title game again, this time with CFP at stake

HARRISONBURG, Va. (AP) — Eddie Ricks III had 13 points in James Madison's 96-64 win over Midway on Sunday night. Ricks added eight rebounds for the Dukes (7-6). Bryce Lindsay scored 13 points, going 5 of 9 (3 for 6 from 3-point range). Elijah Hutchins-Everett went 5 of 10 from the field to finish with 12 points. The Eagles were led by Miguel Shaw, who recorded 19 points and two steals. Robbie Henry added 14 points and five steals for Midway. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .Funding supports trauma-informed mental wellness programs that empower individuals through entrepreneurship and personal development MOUNTAIN VIEW, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- LegalZoom (Nasdaq: LZ) is proud to announce the expansion of its partnership with Defy Ventures, a nonprofit organization dedicated to providing career readiness, personal development, and entrepreneurship training to currently and formerly incarcerated individuals. The expanded partnership will include funding for mental health and wellbeing programs, reinforcing LegalZoom's commitment to creating pathways to economic opportunity for underrepresented communities that face significant challenges due to employment history, race and ethnicity, gender identity, and incarceration. With LegalZoom's support, Defy Ventures will be able to expand its mental health and wellbeing initiatives for its clients, focusing on trauma-informed care that addresses the unique challenges they face. By helping to fund Defy Ventures' mental wellness programs, LegalZoom is helping to ensure that these individuals have access to crucial mental health resources, empowering them not only to build businesses but also to rebuild their lives with dignity and resilience. "Defy Ventures exemplifies the incredible power of resilience and the potential for true transformation. We are honored to extend our partnership to support their mental health initiatives, which are essential for giving people a real second chance,” said Nicole Miller, Chief Legal Officer at LegalZoom and Board Member of Defy Ventures. "Our ongoing investment in Defy Ventures' impactful programs reflects our commitment to social equity and empowering individuals to rebuild their lives and communities.” Defy Ventures offers a range of holistic programs, including CEO of Your New Life , Entrepreneur Bootcamp , and Business Accelerator , which equip individuals with the business and confidence-building skills they need to succeed. The mental health and wellbeing program, first launched in 2023 with funding from LegalZoom, integrates trauma-informed principles into the full suite of Defy's programs, offering a critical layer of support for participants facing past trauma and the challenges of reintegration. These combined efforts had allowed Defy to maintain a three-year recidivism rate of less than 15%, far below the national average. In 2025, LegalZoom will deepen its commitment to Defy Ventures' mental health and wellbeing programs, providing $100,000 in funding to support and expand critical mental health resources. This funding will allow Defy Ventures to: Since the beginning of its partnership with Defy Ventures in 2021, LegalZoom has made a meaningful impact through funding, volunteer support, and product donations, helping Defy transform the lives of individuals re-entering society. Previous contributions from LegalZoom have enabled Defy to: About LegalZoom LegalZoom is a leading online platform for business formation in the United States. Driven by a mission to unleash entrepreneurship, LegalZoom delivers comprehensive legal and compliance products and expertise for small business owners through easy-to-use technology. From free business formations to business management solutions and professional advisory services, LegalZoom supports millions of small business owners and their families throughout the entrepreneurial journey. Founded on the belief that everyone should have affordable access to legal and financial expertise, LegalZoom empowers entrepreneurs to make their dream a reality. For more information, please visit www.legalzoom.com. Contact: [email protected]

Universal Corporation Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended September 30, 2024

James Madison wins 96-64 over Midway

How to Watch Top 25 Women’s College Basketball Games – Monday, November 25

Chris Packham has slammed the Labour government for being “complicit” in the deaths of thousands of dolphins on the Faroe Islands. Some 15 Whitehall departments have no idea if fish they buy is from the Faroe Islands where hundreds of dolphins are brutally slaughtered each year, Freedom of Information requests have revealed. Mr Packham said: “For decades myself and campaigners including Captain Paul Watson have been working to end the senseless killing of these highly intelligent, sentient mammals. “Labour has long touted its strong animal rights record yet is complicit in the deaths of thousands of dolphins taking place so close to our shores. The UK Government must use their power through the free trade deal to put an end to these unnecessary, unregulated and brutal hunts.” Campaigners said the UK’s £1.3billion imports of Faroese fish each year props up the industry which fuels the hunts. Trade Minister Douglas Alexander described the hunts on the island nation, just 230 miles north of Scotland, as “unacceptably cruel” in a letter to campaigners But the Department for Food and Rural Affairs, the body responsible for animal welfare policy, states “the department does not stipulate which countries these products should originate from as part of its contracts.” The Government Property Agency, responsible for many catering contracts across government agencies, confirmed that “GPA does not record the amount of fish or shellfish purchased or its source.” Other bodies with billion-pound budgets who had no policy to rule out fish originating from the Faroese Islands included the departments for Energy and Net Zero, Education, and the Ministry of Defence. Only the Department for Work and Pensions was able to confirm that no fish or shellfish from the Faroe Islands was purchased by the department for their canteens, cafes and event catering last year. Campaigners warn the lack of department buying standards is “completely at odds” with the other Government’s strong commitments to ensuring high animal welfare standards. Animal welfare campaigner Dominic Dyer, chair of Nature 2030, said: “How are we supposed to take this government seriously if it can’t manage to align its opposition to these barbaric hunts within its own departments? “The UK cannot claim to uphold high animal welfare standards while turning a blind eye to the brutal dolphin hunts in the Faroe Islands. “By importing over a billion pounds worth of Faroese fish, we are not just complicit—we are funding this cruelty. The Government must act decisively to align its trade policies with its ethical obligations by ending the import of Faroese fish until these hunts are banned.” The island nation’s dolphin hunts involve powerboats driving the marine mammals to shallow waters before they are killed in designated killing bays with lances and knives. Meanwhile UK Shoppers are overwhelmingly in favour of strengthening food labelling to help avoid produce sourced from countries that do not meet UK animal welfare standards Some 86% shoppers also say clearer food labelling is needed to help them make informed choices in supermarkets. Over 60% of the British public have declared they would avoid buying or eating Faroese fish until the dolphin hunts are stopped. At least 77% of Britons said public buildings, such as schools and hospitals, should not stock Faroese fish and should be more open about the origins of the fish they serve. Campaigners want the UK Government to force supermarkets who choose to stock Faroese fish to make this clear on packaging. A Government review into food labelling is set to finish in spring 2025. A spokeswoman for the Department for Environment, Food and Rural Affairs said: “The UK is strongly opposed to the hunting of any cetaceans, including whales, dolphins and porpoises. “We continue to call on all whaling nations at every appropriate opportunity to cease their whaling activities.”The stock market indexes recently made new all-time highs. A resilient economy, interest rates that should trend down, enthusiasm for an expected corporate-friendly incoming administration, enthusiasm for artificial intelligence (AI), and high-flying tech stocks like Nvidia and Microsoft all play a role in this bull market. Investors should exercise some caution at these levels. Remember that 2021 euphoria quickly turned to dread in 2022. There are pockets of the market that resemble 2021 now. For instance, Palantir 's stock trades for 56 times sales and over 160 times forward earnings. It's a terrific company, but this is a nosebleed valuation by any measure. However, some companies still trade for reasonable valuations with long-term positive trends. Here is one to consider. Don't sleep on Airbnb Vacation habits are changing. Younger generations book vacation rentals at a higher rate than older generations, who stick more to traditional hotels. As shown below, the number of vacation rental users will rise 25% from 2024 to 2029. The trend means that Airbnb ( ABNB 3.06% ) has a long-term tailwind. Airbnb is also highly successful now. Revenue hit $3.7 billion last quarter on 10% year-over-year growth, and operating income reached $1.4 billion on fantastic 37% growth. However, what I like most about the company is the ability to produce free cash flow. Airbnb operates with a lean business model and doesn't have significant capital expenditures (capex) needs, so much of its revenue falls into the company's pocket. Of the $10.8 billion sales over the past 12 months, $4.1 billion was converted to free cash flow, a terrific 38% margin. Having tremendous free cash flow allows Airbnb to fund growth, maintain a fortress balance sheet, and repurchase shares. As of the third quarter, the company reported $11.3 billion in cash and investments against just $2 billion in long-term debt. The company also repurchased $2.6 billion in shares through three quarters of 2024, amounting to more than 3% of the company's current market cap. Is Airbnb stock a good investment? Airbnb stock trades at a similar valuation to its rival Booking Holdings ( BKNG -0.65% ) based on free cash flow, as shown below. ABNB Price to Free Cash Flow data by YCharts This makes sense, as the business models and financial results are similar. It also shows the importance of free cash flow in valuing these companies. Airbnb is trading slightly below its recent average and well below recent peaks. Both are terrific investment options; however, Airbnb's market cap is around half of Booking's, so it has more room to compound. The most significant risk to Airbnb is regulatory. Many localities and homeowners associations have rules limiting short-term rentals. Airbnb works proactively with policymakers to craft mutually beneficial regulations to mitigate the risk. Airbnb will benefit from the long-term trend toward vacation rentals. The rapid rise in users and its top-notch financial results make the stock an excellent long-term pick.

Global leaders have reacted with sorrow to the passing of former U.S. President Jimmy Carter at age 100. Celebrated for his role in the historic peace agreement between Egypt and Israel, Carter's presidency and post-presidency were marked by unwavering commitments to peace and humanitarian efforts. U.S. Presidents, past and present, as well as international heads of state, have expressed condolences, underscoring Carter's significant contributions. President Joe Biden and other leaders highlighted his deep faith, integrity, and commitment to advancing global welfare and security. World leaders such as Canada's Prime Minister Justin Trudeau and France's President Emmanuel Macron honored Carter's legacy, crediting him with changing and uplifting countless lives. His work with the Carter Center and Habitat for Humanity further solidifies his legacy of service. (With inputs from agencies.)Lil Wayne, GloRilla, Camila Cabello to perform at College Football National ChampionshipOutlander: Blood of My Blood - When will Season 2 release? Premiere window revealed